Catalyst Pharmaceuticals Inc (CPRX)

Total asset turnover

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Revenue (ttm) US$ in thousands 491,734 460,482 434,475 411,347 398,204 348,393 302,949 256,480 214,203 191,755 170,465 153,717 140,833 133,539 126,902 120,142 119,073 118,181 119,761 118,994
Total assets US$ in thousands 851,411 772,010 706,360 646,676 471,907 413,211 443,896 407,227 375,630 333,114 267,309 246,972 237,788 223,248 209,130 197,216 192,354 174,860 131,412 117,880
Total asset turnover 0.58 0.60 0.62 0.64 0.84 0.84 0.68 0.63 0.57 0.58 0.64 0.62 0.59 0.60 0.61 0.61 0.62 0.68 0.91 1.01

December 31, 2024 calculation

Total asset turnover = Revenue (ttm) ÷ Total assets
= $491,734K ÷ $851,411K
= 0.58

Total asset turnover for Catalyst Pharmaceuticals Inc has shown a declining trend over the period from March 31, 2020, to December 31, 2024. The ratio started at 1.01 in March 2020 and gradually decreased to 0.58 by December 31, 2024. This indicates that the company generated $0.58 in revenue for every $1 of assets held at the end of 2024.

The decreasing trend in total asset turnover may suggest inefficiency in asset utilization or a decrease in the company's ability to generate sales from its assets. Lower asset turnover could result from various factors such as excess inventory, underutilized capacity, or declining sales relative to assets.

Further analysis and comparison with industry peers are recommended to determine the specific reasons behind the declining total asset turnover and to assess Catalyst Pharmaceuticals' effectiveness in utilizing its assets to generate revenue.